Table 2.
Outcomes of patients treated with HFNT
| Outcomes | Total (n=104) | P value | |
| Prevention of intubation | 67 (64.42%) | ||
| Intubation rate | 37 (35.58%) | ||
| Mortality | 14.44% (n=15) | ||
| Hospital LOS | 10.96 days (±6.04) | ||
| ICU LOS | 6.55 days (±5.31) | ||
| HAP/VAP incidence | 3 (2.94%) | ||
| Day 0 | Day 7–10 | ||
| SF ratio | 123.5 (±42.25) | 234.5 (±120.79) | <0.0001 |
| CXR RALES | 18.17 (±7.87) | 16.13 (±8.79) | 0.033 |
| Heart rate (bpm) | 88.2 (±17.13) | 75.7 (±23.13) | 0.0004 |
| Respiratory rate (breaths/min) | 29.71 (±18.99) | 26.38 (±16.93) | 0.0001 |
CXR, chest X-ray; HAP, hospital-associated pneumonia; ICU, intensive care unit; LOS, length of stay; RALES, Radiographic Assessment of Lung Edema Score; SF ratio, saturation to fraction ratio; VAP, ventilator-associated pneumonia.